ARTICLE | Company News
Gene therapy company Rocket finds public path
September 15, 2017 7:17 PM UTC
Ophthalmic play Inotek Pharmaceuticals Corp. (NASDAQ:ITEK) will merge with gene therapy company Rocket Pharmaceuticals Ltd. (New York, N.Y.). The combined company will retain Rocket's name and will be located in New York. The partners expect the deal to close in 1Q18.
Rocket shareholders will own about 81% of the combined company; Inotek shareholders will own the remainder. Inotek will reduce headcount by 60% to seven employees...
BCIQ Company Profiles
BCIQ Target Profiles